|
Simultaneous Sessions
Monday, December 11, 2006: 3:30 p.m. - 5:00 p.m.
- Mechanisms of Erythropoiesis, Room 315
- Sickle Cell Disease: New Therapeutic Strategies, Room 314
- Regulation of Myeloid Differentiation and Function, Room 224 ABEF
- Lymphocyte Development and Signaling, Room 414 CD
- Antithrombotic Therapy: New Anticoagulants: Factor Xa and Thrombin Inhibitors, Hall F5
- Basic Science and Clinical Practice in Blood Transfusion: Components, Room 109
- Self-Renewal and Survival of Stem Cells, Room 110
- Hematopoiesis: Cytokines and Signal Transduction - Hematopoietic Stem Cell and Myeloid Progenitor Development, Room 311 E-H
- Disordered Gene Expression in Hematologic Malignancy, Room 240
- Leukemias: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis - Philadelphia Chromosome Studies, Room 311 A-D
- Acute Myeloid Leukemia: Biology and Clinical Outcome, Room 330
- Acute Promyelocytic Leukemias and Novel Approaches to AML, Halls F1-F2
- Targeted Therapy of Non-Hodgkin Lymphoma (NHL), Valencia Room BC
- Myeloproliferative Syndromes: Basic II, Valencia Room A
- Myeloproliferative Syndromes: Clinical II, Valencia Room D
- Chronic Lymphocytic Leukemia (CLL) Biology III: Signaling and Microenvironment, Halls F3-F4
- Multiple Myeloma: Immunotherapy, Chapin Theater (Level III)
- Experimental Transplantation: Basic Biology, Immune Function, and Engraftment, Room 230
- Clinical Care: Transplantation: Predictive Factors and Supportive Care, Room 312
- Clinical Care: Infectious Complications, Room 304 E-H
- Clinical Results: Alternative Donor Transplantation and Reduced Intensity Preparative Regimen, Room 304 A-D
- Clinical Results: Autologous Transplantation - Acute Myeloid Leukemia and Amyloidosis, Room 414 AB
- Health Services and Outcomes Research: Thrombosis and Anticoagulant Therapy, Room 224 CDGH
|
